Brown adipose tissue–derived neuregulin 4 attenuates hyperlipidemia and atherosclerosis by activating the hepatic ErbB4/AHR/CYP1A1 signaling pathway
Life Sciences · 2026-10 · 402 · 124580
DOI: 10.1016/j.lfs.2026.124580 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026-10. Verfasst von Yulong Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China. Hauptthemen laut MEDLINE: Neuregulins, Hyperlipidemias, Receptor, ErbB-4, Adipose Tissue, Brown. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Anhui University of Chinese Medicine, National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.
Abstract (Originalsprache)
Hyperlipidemia is a major contributor to atherosclerotic cardiovascular disease, yet effective therapeutic strategies targeting lipid metabolism remain limited. Recent evidence has established brown adipose tissue (BAT) as an endocrine organ that specifically expresses and secretes neuregulin 4 (Nrg4), a key factor in metabolic regulation. However, the mechanism by which Nrg4 controls hepatic lipid metabolism remains unclear. Here, we investigated whether Nrg4 modulates lipid homeostasis via a hepatic Human Epidermal Growth Factor Receptor 4 (ErbB4)-dependent pathway. In hyperlipidemic apolipoprotein E-deficient mice, BAT depletion reduced circulating Nrg4 and worsened dyslipidemia, whereas recombinant Nrg4 reactivated hepatic ErbB4 signaling, alleviated steatosis, improved serum lipid profiles, and reduced atherosclerotic plaques. In AML12 hepatocytes, Nrg4 suppressed palmitate-induced lipid accumulation in an ErbB4-dependent manner. Co-culture experiments further confirmed that activated brown adipocytes protect hepatocytes through secreted Nrg4. Transcriptomic profiling identified cytochrome P450 1A1 (CYP1A1) as one of the most markedly upregulated genes following Nrg4 treatment. Since CYP1A1 is a canonical target of the aryl hydrocarbon receptor (AHR), mechanistic experiments demonstrated that Nrg4 restored the protein expression of ErbB4, AHR, and CYP1A1 that was suppressed by palmitate, and these restorative effects were abolished by ErbB4 knockdown, confirming a novel ErbB4/AHR/CYP1A1 signaling pathway. Collectively, our findings elucidate a novel BAT-liver endocrine pathway through which BAT-derived Nrg4 ameliorates hyperlipidemia and atherosclerosis, identifying a promising therapeutic target for dyslipidemia and its cardiovascular complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China.
- The First Clinical Medical College, Anhui University of Chinese Medicine, Hefei, 230031, China.
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, 230012, China. Electronic address: daimin@ahtcm.edu.cn.
- College of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, China; Anhui Province Key Laboratory of Bioactive Natural Products, Hefei, 230012, China. Electronic address: xiaoyanshi@ahtcm.edu.cn.
Förderung
- Anhui University of Chinese Medicine
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
Zitieren
APA
Yang, Y., Hu, Y., Wu, X., Xu, Z., Zhao, X., Dai, M., & Shi, X. (2026). Brown adipose tissue–derived neuregulin 4 attenuates hyperlipidemia and atherosclerosis by activating the hepatic ErbB4/AHR/CYP1A1 signaling pathway. Life Sciences, 402, 124580. https://doi.org/10.1016/j.lfs.2026.124580
Vancouver
Yang Y, Hu Y, Wu X, Xu Z, Zhao X, Dai M, et al. Brown adipose tissue–derived neuregulin 4 attenuates hyperlipidemia and atherosclerosis by activating the hepatic ErbB4/AHR/CYP1A1 signaling pathway. Life Sciences. 2026;402:124580. doi:10.1016/j.lfs.2026.124580
BibTeX
@article{Yang2026,
author = {Yang, Yulong and Hu, Yue and Wu, Xiqiu and Xu, Zhian and Zhao, Xuan and Dai, Min and Shi, Xiaoyan},
title = {Brown adipose tissue–derived neuregulin 4 attenuates hyperlipidemia and atherosclerosis by activating the hepatic ErbB4/AHR/CYP1A1 signaling pathway},
journal = {Life Sciences},
year = {2026},
volume = {402},
pages = {124580},
doi = {10.1016/j.lfs.2026.124580}
}
EUVIMED